Skip to content

Total Intravenous Anaesthesia: Comparison of two drug combinations Propofol-Ketamine and Propofol-Dexmedetomidine combinations in Total intravenous anaesthesia to evaluate the induction characteristics, maintenance of anaesthesia and recovery characteristics & Side effects.

Total Intravenous Anaesthesia: Comparison of Propofol-Ketamine and Propofol-Dexmedetomidine combinations - TIVA

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/02/012057
Enrollment
100
Registered
2018-02-21
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients undergoing sergical procedures PAC fit

Interventions

Control Intervention1: The comparison of two combinations 1)Propofol and Ketamine 2) Propofol and Dexmedetomedine.: Induction of anesthesia will be done in group 1) with Propofol 1.0 mg/Kgbwt and Keta

Sponsors

Peoples College of Medical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 100 adult patients with ASA Gr I-II between age of 18 to 65 years of age willing for participation in study after explanation of study undergoing short surgical procedures will be includd.They will be devided in two groups 1) group will receive Propofol- Ketamine. combination and group 2) will receive Propofol Dexamedetomedine combination. One capsule of Omeprazole 20 mg and one tab of Alprozolam 0.25 mg given at 10.00 PM previous night of procedure.IV fluid Ringer Lactate will be given for fluid resuscitation. Inductio of anesthesia will be done ingroup 1) with Propofol 1.0 mg/Kgbwt and Ketamine 1.0 mg body wt in group 2) with Propofol 1.0 mg/ bodt wt and Dexmedetomedine 1.0 mg body wt. Maintenance with Propofol 2.0 mg and Ketamine 2.0 mg per kg per hour in group 1) and with Propofol 2.0 mg and Dexmedetomedine 0.7 mg per kg per hour in gropup 2). The vital parameters will be observed during operative procedure and postoperative period. The patients will be followed up for any symptoms and signs and vitals recorded in recovery room.

Exclusion criteria

Exclusion criteria: Patients who didnot give consent for participation. Patients with H/O allergy to any particular drug, allergy to egg or fat, on MAO inhibitors, H/O Liver disorder like jaundice etc. Pregnant woman and patients for long surgeries not included in study.

Design outcomes

Primary

MeasureTime frame
Parameters SpO2, NIBP, ECG and heart rate monitored at interval of 5 min for initial 15 min and then every 10 min interval till end. Patients in both groups were ventilated with 100% Oxygen through circuit attached to circle absorber. All patients in both groups were monitored and followed up in post operative period for any symptoms. The vitals were recorded at 15 min interval in recovery room. It was presumed to have some changes in parameters. Timepoint: Side effects if any with the combinations. Change in vital parameters during procedures and in immediate post operative period were noted

Secondary

MeasureTime frame
There was slight increase in pulse rate in both groups,insignificant change in Blood Pressure,time of drowsiness was more in Ketamine group,nausea and vomiting were comparable in bothTimepoint: There was slight increase in pulse rate in both groups which persisted for brief period of 35 min.,insignificant change in Blood Pressure,time of drowsiness was more in Ketamine group in recovery period, nausea and vomiting were comparable in both

Countries

India

Contacts

Public ContactDr Kanhaiya Lal Kishnani

Peoples College of Medical Sciences & Research Centre

drkishnani@gmail.com07554004010

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026